Clinical trial

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-14

PhasePHASE1

Study timeline

Study start (actual)2024-10-14Date precision: day

Registry last updated2026-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Metastatic Breast Cancerunresolved

Metastatic Ovarian Cancerunresolved

Metastatic Endometrial Cancerunresolved

Metastatic Liver Cancerunresolved

Metastatic Pancreatic Cancerunresolved

Interventions

Sponsors & collaborators

EtiraRx Australia Pty Ltdlead sponsor

Mapped research locations

AdelaideSouth Australia, Australia2 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06533332 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.